This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
BMC Cancer Open Access 08 April 2005
-
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
British Journal of Cancer Open Access 13 August 1999
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Mavridou, D., Gornall, R., Campbell, I. et al. TP53 intron 6 polymorphism and the risk of ovarian and breast cancer. Br J Cancer 77, 676–677 (1998). https://doi.org/10.1038/bjc.1998.108
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.108
This article is cited by
-
Epistatic interaction of Arg72Pro TP53 and −710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival
Molecular and Cellular Biochemistry (2013)
-
Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
BMC Cancer (2005)
-
Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15
Clinical and Translational Oncology (2005)
-
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
British Journal of Cancer (1999)